Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients
Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, Hervé Kovacic, Jean‐Marc Sabatier
Abstract
International audience
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRenin–angiotensin systemMedicineAngiotensin-converting enzyme 2VirologyPeptidyl-Dipeptidase APharmacologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakBlood pressureSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19